This seminar will provide an overview of ongoing Alzheimer’s disease (AD) research at Brigham and Women’s Hospital and Harvard Medical School, while also highlighting the vibrant Boston ecosystem for research and biotechnology. Recent advances and collaborative efforts driving the development of new biomarkers and therapeutic strategies will be presented. Future directions, including strategies to overcome current challenges in immunotherapeutics and the development of novel biomarkers, will also be discussed.

▼Seminar leaflet